Nation's Top Cancer Physicians Gather in Chicago to Discuss New Era of Precision Medicine
Personalized Lifestyle Medicine Institute (PLMI) Thought Leaders Consortium, October 24 - 25
CHICAGO, Oct. 1, 2015 /PRNewswire/ -- Pulitzer Prize-winning author and renowned medical oncologist Siddhartha Mukherjee, MD, joins physicians from Harvard Medical School, Northwestern University and Cancer Treatment Centers of America® (CTCA) to discuss the emergence of personalized medicine in oncology at the Personalized Lifestyle Medicine Institute (PLMI) 2015 Thought Leaders' Consortium conference. The event will be held on Saturday, October 24 through Sunday, October 25 at the Hilton Rosemont, 5550 N. River Rd, Chicago, Ill. CTCA®, a national network of five hospitals that specializes in the treatment of cancer, is sponsoring the program.
Dr. Mukherjee, assistant professor of medicine at Columbia University Medical Center and author of The Emperor of All Maladies: A Biography of Cancer, which was made into a PBS documentary earlier this year, will speak about "Cancer Therapies: The Past, Present and Future." Maurie Markman, MD, President, CTCA® Medicine & Science, will discuss "Personalized Care in the Age of 'Omics.'" Dennis A. Ausiello, MD, Harvard Medical School, will address "Quantitative Human Phenotyping: Opportunities for Convergent Science in the Novel Measurement of Health and Disease" with a discussion about the need to collect data and move care from "episodic and reactive, to continuous and proactive."
Other presenters include: Richard Burt, MD, Northwestern University Feinberg School of Medicine; Nathan Price, PhD, Institute for Systems Biology; and Stacie J. Stephenson, DC, CNS, Chairman of Functional Medicine, CTCA.
Jeffrey S. Bland, PhD, FACN, CNS, founder of PLMI, author of the new book, The Disease Delusion, and considered the "father of functional medicine," is chairing the conference. "The goal of our conference," said Bland, "is to bring together scientists, researchers, clinicians and other medical professionals to inform and debate the future of genomics in health care and personalized cancer therapy."
"An ever-growing body of empirical research is demonstrating how specific genes are involved in the development of cancer," he said. "With this recognition, personalized medicine is a natural extension. In the near-term, the goal of earlier assessment – perhaps even prevention – may be realized through the convergence of genomic tools, personal informatics, epigenetic science and a patient-activated wellness economy. "This gathering will stimulate interaction among experts in informatics, stem cell biology, genomics, epigenetics and cancer therapeutics."
According to Dr. Markman, personalized medicine is becoming increasingly important to patient care at CTCA. "We're just at the beginning of a new era in the evolution of precision cancer treatment," he said. "Discussions such as these with my oncology peers are critical to discovering new ways to treat each patient's individual cancer more effectively."
For more information, visit www.plminstitute.org.
About PLMI
The Personalized Lifestyle Medicine Institute (PLMI) is a not-for-profit entity whose mission is to transform healthcare through the promotion of information, innovation, and implementation of personalized lifestyle medicine. The organization cultivates virtual and in-person networks of collaboration between researchers, clinicians, patients, policy makers, and consumer advocates to bring personalized lifestyle medicine into greater visibility. Additionally, it provides cutting-edge communication about the latest developments in personalized lifestyle medicine through their website and other educational endeavors. By harnessing the interest and input of individuals, thinkers, and innovative leaders, they strive to be global leaders in the emerging field of healthcare. For more information, visit www.plminstitute.org.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America® (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-based complementary therapies that support patients physically and emotionally, enhancing their quality of life while reducing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Consistently rated among U.S. hospitals that deliver the highest quality of care and patient experience, CTCA provides patients and their families with comprehensive information about their treatment options and encourages their active participation in treatment decisions. For more information, visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter.
Contact: Ellen Crane
Office: (561) 923-3149
[email protected]
SOURCE Cancer Treatment Centers of America
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article